Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.

Morales C, de Luis D, de Arellano AR, Ferrario MG, Lizán L.

Diabetes Ther. 2015 Dec;6(4):593-610. Epub 2015 Nov 20.

2.

Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.

Ferrario MG, Lizán L, Montagnoli R, Ramírez de Arellano A.

Prim Care Diabetes. 2016 Jun;10(3):220-6. doi: 10.1016/j.pcd.2015.10.002. Epub 2015 Nov 3.

PMID:
26546244
3.

[Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].

Cosin Sales J, Fuentes Jiménez FJ, Mantilla Morató T, Ruiz E, Becerra V, Aceituno S, Ferrario MG, Lizán L, Gracia A.

Clin Investig Arterioscler. 2015 Sep-Oct;27(5):228-38. doi: 10.1016/j.arteri.2014.11.003. Epub 2015 Jan 29. Spanish.

PMID:
25640158
4.

Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain.

Ramírez de AA, Morales C, De LD, Ferrario MG, Lizán L.

Value Health. 2014 Nov;17(7):A343. doi: 10.1016/j.jval.2014.08.686. Epub 2014 Oct 26. No abstract available.

5.

Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Travé G.

Science. 2013 Feb 8;339(6120):694-8. doi: 10.1126/science.1229934.

Supplemental Content

Loading ...
Support Center